The application of terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining with beta-actin further supported this finding, with a higher level of apoptotic cells present in the Defender®-treated tumor sections compared to the untreated sections (Figure 3F). Here, ACTB is linked to neoplasm.